Zimmer Biomet Holdings Inc (ZBH)
Healthcare
Medical Devices
93.90 $
-1.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Zimmer Biomet Holdings Inc (ZBH)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.7% of the shares are freely tradable; institutional investors hold 106.6%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
106.6%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
0.2%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
99.7%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
7.9%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
194Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Dodge & Cox | 12.17 | 23,542,700 | +0.2 | 03/31/2026 |
| Vanguard Group Inc | 12.14 | 23,483,741 | +0.8 | 12/31/2025 |
| BlackRock Inc | 7.93 | 15,340,806 | -1.7 | 03/31/2026 |
| Harris Associates L.P. | 6.70 | 12,959,939 | +5.7 | 03/31/2026 |
| Vanguard Capital Management, LLC | 6.61 | 12,793,412 | +0.0 | 03/31/2026 |
| Capital Research & Mgmt Co - Division 3 | 4.71 | 9,119,222 | +27.9 | 03/31/2026 |
| State Street Corp | 4.56 | 8,825,127 | +0.0 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 4.47 | 8,650,228 | +0.0 | 03/31/2026 |
| T. Rowe Price Associates, Inc. | 4.14 | 7,999,712 | -41.3 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Dodge & Cox Stock I | 8.04 | 15,549,900 | +0.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.